Pfizer last month completed an acquisition of biotech firm Metsera, deepening its portfolio of products in the fast-growing market for weight loss drugs - Copyright ...

Pfizer shares jumped 8% to the day's high of Rs 5,422.95 on BSE on Wednesday after the US drugmaker agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump ...

Pfizer shares are trading in the mid-$20s as investors grapple with a critical question: is this battered pharmaceutical giant destined to remain stuck in neutral, or does its aggressive push into ...

The Trump administration and Pfizer PFE announced an agreement on Sept. 30 that includes most-favored-nation pricing for Pfizer’s drugs in Medicaid programs, discounts for direct sales of Pfizer drugs ...

Shares of Pfizer rose after The Wall Street Journal reported the company would reveal a plan later Tuesday alongside the Trump Administration to lower drug costs. The stock rose 4% to $24.82. It is ...

Wilsey Asset Management increased its Pfizer position by 118,248 shares worth an estimated $2.9 million in the third quarter. This transaction value is equal to 0.5% of the fund’s 13F reportable ...

Pfizer (NYSE:PFE) shares are trading higher Wednesday after President Donald Trump announced a drug-pricing deal with the company. As part of the agreement, Pfizer will receive a three-year grace ...

Novo Nordisk has launched a rival bid for U.S. obesity biotech firm Metsera, directly challenging an existing offer from Pfizer. The move, announced Thursday, escalates the competition between the two ...

Pfizer shares surged 14% over two trading days this past week after joining with Trump’s administration to announce an agreement they positioned as both bolstering U.S. leadership in biopharma ...